Literature DB >> 20142029

Sleep-disordered breathing and heart failure: focus on obstructive sleep apnea and treatment with continuous positive airway pressure.

Mahdi Chowdhury1, Suzanne Adams, David J Whellan.   

Abstract

BACKGROUND: Among patients with heart failure, sleep-disordered breathing is a common problem, with a prevalence ranging from 24% to 76%. Encompassed within the general category of sleep-disordered breathing are 2 types of sleep apnea: obstructive sleep apnea (OSA) occurs when the oropharyngeal musculature relaxes, causing a collapse of the upper airway, and central sleep apnea occurs when the brain stem fails to stimulate breathing. METHODS AND
RESULTS: This article focuses on the relationship between heart failure and OSA, the treatment of OSA with continuous positive airway pressure (CPAP), and the role of CPAP in improving such effects of heart failure as ejection fraction, blood pressure, sympathetic activity, sleepiness, heart rate, and mortality.
CONCLUSIONS: It is important to distinguish the type of sleep-disordered breathing a patient may have. Further studies are needed to elucidate the effects of CPAP and other therapies. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20142029     DOI: 10.1016/j.cardfail.2009.08.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  3 in total

Review 1.  Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea.

Authors:  Frederico T Barbosa; Michele P Silva; Luís Eduardo S Fontes; Daniela V Pachito; Tamara Melnik; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2021-09-23

Review 2.  Obstructive Sleep Apnea in Heart Failure: Review of Prevalence, Treatment with Continuous Positive Airway Pressure, and Prognosis.

Authors:  Himad K Khattak; Faisal Hayat; Salpy V Pamboukian; Harvey S Hahn; Brian P Schwartz; Phyllis K Stein
Journal:  Tex Heart Inst J       Date:  2018-06-01

3.  Sympatho-renal axis in chronic disease.

Authors:  Paul A Sobotka; Felix Mahfoud; Markus P Schlaich; Uta C Hoppe; Michael Böhm; Henry Krum
Journal:  Clin Res Cardiol       Date:  2011-06-19       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.